The Merger of AbbVie and Allergan Is A Bad Idea for Consumers
Just last month, the drug company AbbVie announced that it was going to acquire Allergan, the drug company that makes Botox, for $63...
Judge Leon Hears Oral Arguments on CVS-Aetna Merger
On Friday, July 19th, Judge Richard Leon of the District Court for the District of Columbia heard oral arguments from supporters and...
All Eyes Are on Congress for Lowering Drug Costs
The Trump administration's efforts to lower prescription drug prices are in trouble. Just last week, the administration abruptly withdrew...
Connecticut Governor Signs Law Regulating PBMs
In a victory for consumers, pharmacists, and advocates for lower drug costs, Connecticut Governor Ned Lamont signed into a law a bill...
Trump Administration Abandons Proposed Rebate Rule To Lower Drug Prices
This morning the Trump administration abandoned its proposed rebate rule to eliminate safe harbor protection for most Medicare rebates...
The Cornyn-Blumenthal Bill is An Important First Step Toward Stopping Patent Thickets and Product Ho
Prescription drug prices are far too high, and many Americans are being forced to choose between paying for their medicines and other...
Several Proposals to Reduce Drug Prices in Congress
The 4th of July is over and Congress is back in session. One of the most important issues for policymakers, health care experts, and...
This Year, Drug Prices Are Rising Rapidly
In the first six months of 2019, prescription drug costs are rising rapidly, despite promises from legislators and the Trump...
Senator Tina Smith Introduces Bipartisan Bill to Lower Insulin Costs
Fifteen years ago patients with diabetes would have paid about $175 for a 20-milileter long vial of insulin. Today they have to pay...
Consumer Groups Submit Brief Opposing CVS-Aetna Merger, Saying Final Judgment Is Totally Inadequate
On Friday, June 21st, respected antitrust lawyers David Balto and Andre Barlow submitted a brief opposing the CVS-Aetna merger on behalf...
